TOPICS No. 40

First Page		Document Content
Date: 2009-05-07 02:23:52 Multiple myeloma Thalidomide Angiogenesis Lenalidomide Plasma cell leukemia Medicine Immunosuppressants Hematologic neoplasms		TOPICS No. 40 Add to Reading List Source URL: www.med.miyazaki-u.ac.jp Download Document from Source Website File Size: 200,52 KB Share Document on Facebook

	DUAL FUNCTION HDAC AND PI3K INHIBITOR CUDC-907 AFFECTS CANCER CELLS AND THE TUMOR MICROENVIRONMENT IN HEMATOLOGICAL MALIGNANCIES Inc., Lexington, MA; 2Department of Medicine, Memorial Sloan-Kettering Cancer Center, New DocID: 1geP2 - View Document
	REVIEW Continuous therapy with lenalidomide in multiple myeloma by Nizar Bahlis, MD DocID: 1aydF - View Document
	Molecular Diagnosis of Myeloid Neoplasias and Solid Tumors First report of mutations detected in the gene for NF-E2 Technology Myeloproliferative Neoplasms (MPN) are a group of several distinct, but clinically related ma DocID: 1adts - View Document
	CIBMTR 2015 New Working Committee Studies Working Committee Study # Title DocID: 1a43D - View Document
	CURRICULUM VITAE Oscar F. Ballester, M.D. LUGAR Y FECHA DE NACIMIENTO: Buenos Aires, Argentina DocID: 16ytv - View Document